Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials

Overview of attention for article published in Frontiers in Genetics, September 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter: 11 X users

patent: 1 patent

Citations

dimensions_citation: 111 Dimensions

Readers on

mendeley: 144 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 11 X posts from 11 X users, with an upper bound of 45,337 followers.

Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials https://t.co/A2DQbKsftP

25 May 2022

Reply Repost Favourite

RT @FrontGenetics: New Research: Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials: Chemothe…

11 Oct 2020

Reply Repost Favourite

RT @FrontGenetics: New Research: Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials: Chemothe…

10 Oct 2020

Reply Repost Favourite

New Research: Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials: Chemotherapy is one of the most established and effective treatments for almost all types of cancer. However, the elevated toxicity… https://t.c

10 Oct 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.